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THE goal of our study was to assess the chemotactic
activity for eosinophils (ECA) and neutrophils (NCA)
and  histamine  releasing  activity  (HRA)  in  crude
supernatants of mononuclear cells in monosensitized
atopic asthmatics and healthy controls. Chemotactic
activity  for  ECA  and  neutrophils  was  measured  in
supernatants  of  cultured  mononuclear  cells  with
modified Boyden’s chamber and HRA was assessed on
healthy donor basophils. With respect to ECA genera-
tion  two  distinct  subgroups  of  subjects  were  dis-
tinguished: releasers [ECA (+)] and non-releasers [ECA
(–)]. In atopic and non-atopic ECA (+) the mean ECA
index was 3.78 ± 0.49 and 2.47 ± 0.27 respectively (P
>  0.05).  Supernatants  from  the  remaining  subjects
(seven of 22 atopic and five of 11 non-atopic) did not
express ECA, but revealed significant inhibitory activ-
ity  for  chemokinesis  of  eosinophils  (mean  chem-
otactic index 0.25 ± 0.16 and 0.48 ± 0.22 for atopic and
non-atopic  non-releasers  respectively).  Stimulation
with antigen of MNC from atopic and with PHA from
non-atopic  ECA  (–)  restored  cells  ability  to  release
ECA.  Sephadex  gel  chromatography  revealed  that
supernatants  of  MNC  contained  chemotactic  and
chemokinesis  inhibitory  activity  in  different  frac-
tions. The spontaneous productions of NCA and HRA
by  mononuclear  cells  was  similar  in  ECA  releasers
and  non-releasers,  although  the  HRA  was  higher
following stimulation with PHA in the non-atopic ECA
(+) subgroup. Our study demonstrated, for the first
time,  that  MNC  are  capable  of  generating  not  only
chemotactic activity but also chemokinesis inhibitory
activity for eosinophils.
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Introduction
Bronchial asthma is a chronic inflammatory process,
characterized  by  the  influx  and  accumulation  of
eosinophils,  neutrophils,  lymphocytes  and  mono-
cytes/macrophages  in  the  airway  mucosa.1 An
increased  number  of  eosinophils  was  observed  in
bronchial  mucosa  and  in  bronchio-alveolar  lavage
(BAL)  in  patients  with  seasonal  and  perennial
asthma.2 The eosinophilic influx after allergen provo-
cation is accompanied by the increase of eosinophils
chemotactic activity (ECA) in BAL.3,4 Similarly natural
exposure to allergen induces the increase of the ECA
in bronchoalveolar lavage and in serum.3 Our earlier
studies also demonstrated the presence of ECA in the
serum  of  patients  with  atopic  asthma  as  well  as
chemotactic  activity  for  neutrophils  (NCA)  in  nasal
lavage in patients suffering from pollinosis.5,6 These
data suggest that mechanisms initiated as a response
to  allergen  leading  to  release  of  chemotactic  mole-
cules, which are responsible for the selective influx of
eosinophils to the lungs.
Mononuclear  cells  play  an  important  role  in  the
development of allergic inflammation by the generat-
ing  of  cytokines  with  proinflammatory  properties,
thus  participating  actively  in  the  generation  of  the
effector  phase  of  allergic  inflammation.7–12 Several
cytokines,  e.g.  RANTES  or  MCP,  have  eosinophil
chemotactic  activity  and  additionally  may  cause
basophil  degranulation  and  release  histamine.13 –15
Other mononuclear cell-derived cytokines (e.g. IL–8
and  MCP–1)  have  NCA  and  HRA.16 –18 Acting  in
concert  with  other  chemotactic  agents  originating
from mastocytes and basophils (e.g. PAF, LTB4) these
cytokines induce the influx of cells into the site of the
allergic  reaction.  Most  studies  have  focused  on  the
measurement  of the release of clearly defined cyto-
kines by MNC and on the effect of these cytokines in
isolated  biological  systems.19–21 However,  activated
inflammatory  cells  release,  at  the  same  time  or
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effect  is  the  result  of  complex  and  not  completely
understood  interactions. Thus, measurement  of  bio-
logical  activity  of  ‘crude’  supernatants  of  antigen-
stimulated  cells  may  provide  observations  more
relevant to in vivo situations, than measurement of a
single mediator or a cytokine.
The aim of our study was to investigate the ability
of MNC to spontaneous and antigen-induced genera-
tion  of  chemotactic  activity  for  eosinophils  and
neutrophils as well as HRA in a group of asthmatic
patients, allergic to the house dust mite antigen Der p
I. The results obtained in the asthmatic patients were




The study included 22 patients (mean age 35 ± 7.19
years; 12 female and 10 men) with perennial atopic
bronchial asthma and clinically dominating allergy to
house dust mites. All patients had positive skin prick
tests with Der p I allergen. No patient was on inhaled
oral  corticosteroids  for  at  least 2  weeks before  the
study. Methyloxantins  or  short-acting  antihistamines
were  stopped  at  least  72 h  before  obtaining  their
blood  samples.  A  control,  non-atopic  group  com-
prised  11  healthy  subjects  without  any  complaints
concerning  the  respiratory  tract  and  with  negative
skin prick tests to a battery of inhalant allergens.
MNC isolation and culture
Mononuclear  cells  were  isolated  with  Boy¨ um’s
method.22 In brief, 20 ml of heparinized venous blood
was mixed with PBS in 1:3 proportion, then carefully
stratified on ‘Lymphoprep’ gradient (Pharmacia) and
centrifuged  at  400 ´ g for 20 min. The ring, which
formed on the borderline of the phases, was carefully
collected  and  rinsed  in  phosphate  buffer  pH  7.4
without Ca++ and Mg++ as well as 0.036% glucose so
that the number of cells equalled 2 ´ 106 ml. Next, the
cells were cultured according to Theuson’s method.23
Culture  medium  consisting  of  PBS  with  Ca++ and
Mg+ + or 0.036% glucose and 0.1% bovine albumin was
used. Der p I allergen in the concentration 10–2 m g/ml
(in  the  asthmatic  subjects)  or  PHA  mitogen  in
concentration  25 m g/ml  (in  healthy  subjects)  were
added  to  cell  suspension  and  the  samples  were
preincubated for 4h in the incubator with 5% CO2
and  95%  humidity  at  37°C.  Then  the  cells  were
centrifuged for 20 min 400 ´ g, washed twice in PBS
without  Ca+ + and  Mg+ +,  suspended  in  the  primary
medium  volume  and  cultured  for  24 h  in  the  same
conditions.  Cells  cultured  in  the  medium  alone
(spontaneous cultures) served as a control. Then the
samples  were  centrifuged  for  20 min  at  400  ´ g,
supernatants dialysed in PBS for 24 h and frozen until
ECA, NCA and HRA activities were measured.
Measurement of ECA and NCA
Granulocytes from a healthy donor, previously tested
for  cells  chemotactic  activity,  were  isolated  using
Boy¨ um’s  method.22 Chemotaxis  was  measured  by
applying modified Boyden’s method using a 48-well
chamber  (Neuroprobe;  Bethesda,  MD,  USA)  and
Millipore  filters  PVP-free  with  pore  diameter  5 m m
and  10 m m  thick.24,25 To  the  specified  wells  at  the
bottom of  the  chamber 30 m l  of  the  studied super-
natants were added in triplicate, then the filter was
applied  and  the  whole  chamber  assembled. To  the
wells of the upper part of the chamber 25 m l of the
previously isolated granulocytes suspended in culture
medium  2 ´ 106 ml were  added. The  chamber was
incubated for 90 min in the incubator with 5% of CO2
and 95% humidity at 37°C. Subsequently the chamber
was  disassembled,  the  filter  preserved  and  stained
with Wright–Giemsa and Chromotrope 2R. The filters
were assessed in light microscope at 500´ magnifica-
tion  by  an  investigator  who  was  unaware  of  the
design of the experiment. Chemotactic activities in
the studied supernatants were estimated by counting
granulocytes  (eosinophils  or  neutrophils)  in  five
standardized  viewing  areas.  Chemotaxis  was
expressed as chemotactic index CI = B/A; B being the
number of cells migrating to the supernatant, and A
the  number  of  cells  migrating  to  the  control
medium.
Measurement of HRA
To evaluate the supernatants derived HRA the method
of Siriganian was used.26 Basophils from the healthy
donor were isolated as previously described13 and to
100 m l of the cell suspension (2 ´ 106 cells/ml), 400 m l
of the examined supernatant was added. The samples
were  incubated  at  37°C  for  30min  while  carefully
stirred, and then cells were cooled rapidly to 4°C and
centrifuged  for 8 min  (1500/min, temperature 4°C).
The supernatants (containing released histamine) and
the  sediments  were  secured  by  freezing. Histamine
was assessed with the spectrofluorometric method.26
The read-outs (in relation to the standard curve for
histamine)  were  carried  out  on  an  LS  50  spectro-
fluorometer  (Perkin-Elmer).  HRA  was  expressed  as
the percentage of the released from basophils hista-
mine according to the following formula:
%HRA =
Histamine in the basophils
supernatant ´ 100
Histamine in the basophils
supernatant + histamine in the sediment
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by gel column chromatography
The approximate molecular weight of the chemotactic
activity was determined. Supernatants obtained from
MNC (from three asthmatic and three healthy subjects)
were stratified on a column containing Sephadex gel
G–75  (by  Pharmacia)  at  flow  rate  of  12 ml/h. The
mononuclear cell culture supernatant fluid was eluted
with PBS. Two-ml fractions were collected and ana-
lysed in duplicate for ECA, NCA or HRA. A kit (Sigma)
for molecular weight as standard for column chroma-
tography  was  used.  Protein  concentration  in  each
fraction was measured at absorbency 280 nm.
Statistical analysis
The statistical analysis was performed with Student’s
d-test and t-test, preceded by evaluation of normality
with F-test. In all cases, a P value less than 0.05 was
considered significant.
Results
ECA release by mononuclear cells from atopic
patients
Significant ECA was measured in the supernatants of
mononuclear cells isolated from 14 out of 22 asthmatic
patients and the average chemotactic index for this
subgroup  [ECA  (+)]  was  3.78  ±  0.49.  Supernatants
obtained from the remaining eight patients not only
did  not  express  chemotactic  activity,  but  clearly
inhibited the migration (chemokinesis) of eosinophils.
The average value of the chemotactic index in  this
group was 0.25 ± 0.16. This subgroup was denoted as
non- releasing ECA [ECA (–)].
Stimulation of the mononuclear  cells from atopic
asthmatic patients with Der p I antigen did not affect
the mean ECA for the whole group (n = 22; before
stimulation the mean chemotactic index  was  2.5 ±
0.48; after stimulation 2.45 ± 0.69; P > 0.05). However
in  the  ECA  (+)  subgroup,  antigen  stimulation  con-
siderably decreased the activity in 10 of 11 patients and
the mean ECA index was 1.98 ± 0.49 (P < 0.05). In
contrast, in the ECA (–) subgroup, after stimulation
with antigen, the increase in eosinophil chemotactic
activity was revealed in seven out of eight examined
patients  (the  mean  value  of  chemotactic  index
increased to 3.73 ± 1.73; P < 0.05) (Fig. 1).
ECA release in healthy individuals
The mean ECA in healthy individuals was similar to
mean ECA in atopic patients (P > 0.05). In the group
of healthy individuals significant ECA was present in
six out of 11 examined supernatants [ECA  (+)] and
the  remaining  supernatants  [ECA  (–)],  had  sup-
pressive effect on chemokinesis of eosinophils. The
mean  index in  the ECA (+) and ECA  (–) subgroups
were 2.44 ± 0.27 and 0.48 ± 0.22 respectively (Fig. 2).
Stimulation of MNC with Der p I antigen did not affect
ECA generation in control patients (data not shown).
Release of ECA and ECIA by mononuclear cells
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FIG. 1. ECA  generation by mononuclear cells  (MNC)  from
atopic asthmatic patients. *P<0.05 compared with sponta-
neous release. Sp.–spontaneous release; Der p I–stimulated
release with Der p I. Mean value.
FIG. 2. ECA  generation by mononuclear cells  (MNC)  from
healthy non-atopic subjects. *P<0.05 compared with sponta-
neous release. Sp.–spontaneous  release;  PHA–stimulation
release. Mean value.After  stimulation  with  phytohaemagglutinin  (PHA)
the mean value of ECA index increased to 4.13 ± 1.22
for the ECA (+) subgroup and 3.19 ± 1.1 for the ECA
(–) subgroup (P < 0.05) (Fig. 2).
NCA and HRA release from MNC atopic
patients
Mononuclear  cells  supernatants  from  all  atopic
patients contained significant neutrophil chemotactic
activity  (NCA)  but  there  were  no  significant  differ-
ences between the values of chemotaxis index in the
ECA (+) or ECA (–) subgroups (mean 2.48 ± 0.27; 2.11
±  0.22  for  both  groups  respectively)  (Table  1).
Stimulation of MNC with Der p I antigen did not affect
neutrophil chemotactic activity neither in the ECA (+)
nor ECA (–) groups.
A significant HRA was found in MNC supernatant of
22 asthmatic patients (mean 29.33% ± 1.80) with no
difference between ECA (+) or ECA (–) patients (P >
0.05). There  was  an  increase  in  the  percentage  of
histamine  release  from  basophils  in  response  to
supernatants obtained from antigen stimulated cells
comparing  to  spontaneous  culture  supernatants,
however only the increase in the ECA (+) group was
significant (P < 0.05) (Table 1).
NCA and HRA in the MNC supernatants of
healthy individuals
Mononuclear  cells  from  the  healthy  subjects  gen-
erated neutrophil chemotactic activity (NCA) and the
mean chemotaxis index was similar to atopic patients
(P > 0.05). There was no difference in NCA between
J. Grzegorczyk et al.
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Table 1. Generation of NCA and HRA by mononuclear cells from control non-atopic subjects and from asthmatic patients
sensitive to Der p I antigen; *P < 0.05 compared with non-stimulated cells; ‡P < 0.05 compared with ECA (+) subgroup
Control non-atopic subjects Asthmatic patients
NCA index ECA (+) n=6 ECA (–) n=5 ECA (+) n=14 ECA (–) n=8
Spontaneous 1.85 ± 0.14 1.41 ± 0.26 2.48 ± 0.27 2.11 ± 0.22
Stimulated
a 1.50 ± 0.08 1.40 ± 0.21 2.27 ± 0.20 2.15 ± 0.13
HRA %
Spontaneous 20.80 ± 1.76 21.99 ± 2.98 30.91 ± 1.84 27.09 ± 3.54
Stimulated
a 17.75 ± 1.63 31.76 ± 1.65*‡ 41.77 ± 1.50* 36.80 ± 1.46
a The cells were stimulated with PHA or Der p I antigen in non-atopic and atopic subjects respectively.
FIG. 3. Gel column chromatography analysis of ECA and HRA generated by mononuclear cells (MNC) from atopic patients
(supernatants pooled from three patients).ECA (+) and ECA (–) non-atopic subjects and stimula-
tion of cells with PHA did not affect NCA. HRA was
present in all supernatants from non-atopic subjects
(mean  21.34%  ±  1.58)  although  was  significantly
lower compared with atopic patients (mean 29.52% ±
1.74;  P<0.05).  After  stimulation  with  PHA,  a  sig-
nificant increase in HRA was observed only in ECA (–)
subjects (Table 1).
Partial purification of chemotactic activity
Figure 3 shows a typical profile of ECA and HRA along
with  the  total  protein  concentrations  measured  in
each  fraction  of  pooled  supernatants  from  three
atopic  asthmatic  patients.  Eosinophil  chemotactic
activity (defined as chemotactic index above 1.5) was
observed in several fractions. One peak was located
above 67kD; the second about 29 kD but the highest
ECA (range 4.9–6.6) was observed in fractions with
molecular weight below 6 kD. Significant eosinophil
chemokinesis  inhibitory  activity  was  detected  in
fractions  with  molecular  weight  between  14.5  and
6 kD. Strong HRA activity (expressed as percentage of
histamines released from basophils) was observed in
fractions  with  apparent  molecular  weight  between
67 kD and 14.5 kD.
In pooled MNC supernatants from control subjects
(Fig.  4),  the  first  peak  of  ECA  was  found  in  area
corresponding to molecular weight above 67 kD. The
second peak with significant ECA was present in the
area  of  14.5 kD  and  the  third  peak  below  6 kD.
Significant eosinophil chemokinesis inhibitory activ-
ity  was  present  in  fractions  with  molecular  weight
around 29 kD. HRA  was present in several fractions
extending  from  67 kD  (48.8%  histamine  release);
29 kD (30.2% histamine release) and 14.5 kD (36.08%
histamine release).
Discussion
In  this  study  we  demonstrated,  that  mononuclear
cells  isolated  from  patients  suffering  from  atopic
asthma and sensitized to house dust mite antigen, as
well  as  from  healthy  individuals,  generate  sponta-
neously  ECA.  However,  atopic  and  non-atopic  sub-
jects  demonstrated  individual  variation  in  ability  to
release spontaneously chemotactic activity for eosino-
phils.  In  about  one-third  of  atopic  patients  and  in
about half of control non-atopic subjects the chem-
otactic activity was not observed. In fact the super-
natants  from  these  ECA  (–)  subjects  had  strong
blocking  effect  on  chemokinesis  of  eosinophils.
Although  the  release  of  ECA  by  MNC  was  docu-
mented in several studies27,28 to our knowledge this is
the  first  study  reporting  the  release  of  inhibitory
activity towards eosinophil chemokines.
Release of ECA and ECIA by mononuclear cells
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FIG.  4.  Gel  column  chromatography  analysis  of  ECA  and  HRA  generated  by  mononuclear  cells  from  healthy  subjects
(supernatants polled from three subjects).Although  the  mononuclear  cell-derived  ECA  has
not been well characterized it was documented that
several cytokines (e.g. IL–5, RANTES or Eotaxin) and
non-peptide  mediators  (e.g.  PAF,  LTB4)  may  be
involved in this activity.29The nature of the eosinophil
chemotactic  inhibitory activity  (ECIA) is  more diffi-
cult to refer to any specific cytokine or mediator. Gel
column  chromatography  revealed  that  in  atopic
patients the major inhibitory activity was present in
fractions with molecular weight from 14.5 kD to 6 kD;
in  non-atopic  controls  the  ECIA  was  present  in
fractions around 29 kD. These molecular sizes corre-
spond  to  the  molecular  weights  of  cytokines  gen-
erated by mononuclear cells. Although to our knowl-
edge  no  specific  cytokine  with  ECIA  has  been
reported.  In  addition,  in  atopic  patients,  inhibitory
activity  was  also  observed  in  low-molecular-weight
fractions. This activity may correspond to non-peptide
mediators  released  by  MNC,  e.g.  eicosanoids  or
histamines  released  from  basophils,  which  could
contaminate MNC preparations. Accordingly, we have
recently reported inhibition of eosinophil chemotaxis
to  RANTES  after  incubation  of  eosinophils  with
histamine.30 Although to our knowledge the presence
of eosinophil chemokinesis inhibitory activity has not
yet  been  reported,  a  generation  of  cytokines  with
reciprocal  biological  effects  has  been  previously
described. Alam et al.31 described a release by MNC
from asthmatic patients with both histamine releasing
activity  and  histamine  release  inhibitory  activity.
These activities were subsequently identified as spe-
cific cytokines; HRA consisted mostly of MCP–1 and
RANTES, while IL–8 was considered to be responsible
for histamine release inhibitory activity.
In our study gel chromatography revealed that MNC
supernatants contained both chemotactic and eosino-
phil  chemokinesis  inhibitory  activity  in  different
fractions.  Furthermore,  stimulation  of  ECA  ‘non-
releasing’  mononuclear  cells  in  either  a  specific
(antigen)  or  non-specific  manner  (PHA)  resulted  in
the appearance of ECA with magnitude similar to that
observed  in  spontaneous  ECA  (+)  supernatants.  It
may suggest that cell activation results in generation
(release)  of  chemotactic  molecules,  that  overweigh
the effect of inhibitory molecules. Alternatively, it is
possible that the activation of mononuclear cells may
decrease  the  release  of  ECIA,  thus  allowing  for
unopposed  activity  of  molecules  with  chemotactic
activity.
When  we  analysed  neutrophil  chemotactic  and
histamines release activity in  subgroups of patients,
no differences in the spontaneous generation of NCA
and HRA were observed between ECA (+) and ECA
(–) subjects, indicating that the heterogeneity of the
cytokines release could be selective, being restricted
only  to  ECA.  However,  HRA  could be  differentially
modulated  by  non-specific  stimulus  (PHA)  in  sub-
groups  non-atopic  patients,  with  only  ECA  (–)  sub-
jects demonstrating an increase in HRA. Gel column
chromatography  analysis  showed  heterogeneity  of
molecular  weight  for  all  examined  activities  (ECA,
NCA  and  HRA)  indicating  multifactoral  nature  of
relatively simple in vitro cellular responses.
It  has  been  documented  that  the  activation  of
eosinophils with the cytokines, which are synthesized
and excreted, by mononuclear cells may be vital for
the  development  of  allergic  inflammation  in  the
respiratory  tract.31 The  immigration  of  eosinophils
into the tissues is conditioned by the presence of Th2-
cell-derived  IL–5,  to  which  a  significant  role  in
maturing and activation of eosinophils is attributed.10
Other  molecules,  which  activate  eosinophils  and
basophils and have chemotactic activity for these cells
include RANTES and other CC chemokines: MCP–1,
MCP–2, MCP–3, MCP–4, Eotaxin, MIP–1a , MIP–1b ,
MIP–1g .14,17 Our study was not aimed at determining
which of the known cytokine is responsible for the
eosinophil signalling. We can speculate however, that
ECA measured in chemotactic assay results from the
coordinated  activity  of  a  number  of  chemotactic
cytokines with both pro- and anti-chemotactic activ-
ity.  Our  results  emphasize  a  complicated  nature  of
allergic  inflammation,  which  may  not  be  visible,
when  a  single  mediator  or  cellular  component  is
studied.  These  data  also  stress  the  relevance  of
studying  biological  activities  of  crude  cells/tissues
products in addition to analysis of generation of well-
defined mediators. Such an approach may allow for
the  better  understanding  of  complex  relations,
between  the  different  mediators  present  in  the
biological system, where the final biological effect of
a  single  mediator  (cytokine)  depends  on  its  inter-
actions with other factors.
In conclusion we demonstrated that mononuclear
cells isolated from the  peripheral  blood of patients
with  atopic  asthma  and  from  healthy  individuals
generate  in  vitro,  not  only  eosinophil  chemotactic
activity, but also eosinophil chemokinesis inhibitory
activity. MNC of subjects generating eosinophil chem-
okinesis inhibitory activity were capable of producing
ECA after stimulation with antigen or PHA in atopic
and control subjects respectively.
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